Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Language
Publication year range
1.
Leukemia ; 31(1): 107-114, 2017 01.
Article in English | MEDLINE | ID: mdl-27416912

ABSTRACT

This randomized, phase III, open-label, multicenter study compared carfilzomib monotherapy against low-dose corticosteroids and optional cyclophosphamide in relapsed and refractory multiple myeloma (RRMM). Relapsed and refractory multiple myeloma patients were randomized (1:1) to receive carfilzomib (10-min intravenous infusion; 20 mg/m2 on days 1 and 2 of cycle 1; 27 mg/m2 thereafter) or a control regimen of low-dose corticosteroids (84 mg of dexamethasone or equivalent corticosteroid) with optional cyclophosphamide (1400 mg) for 28-day cycles. The primary endpoint was overall survival (OS). Three-hundred and fifteen patients were randomized to carfilzomib (n=157) or control (n=158). Both groups had a median of five prior regimens. In the control group, 95% of patients received cyclophosphamide. Median OS was 10.2 (95% confidence interval (CI) 8.4-14.4) vs 10.0 months (95% CI 7.7-12.0) with carfilzomib vs control (hazard ratio=0.975; 95% CI 0.760-1.249; P=0.4172). Progression-free survival was similar between groups; overall response rate was higher with carfilzomib (19.1 vs 11.4%). The most common grade ⩾3 adverse events were anemia (25.5 vs 30.7%), thrombocytopenia (24.2 vs 22.2%) and neutropenia (7.6 vs 12.4%) with carfilzomib vs control. Median OS for single-agent carfilzomib was similar to that for an active doublet control regimen in heavily pretreated RRMM patients.


Subject(s)
Adrenal Cortex Hormones/administration & dosage , Cyclophosphamide/administration & dosage , Multiple Myeloma/drug therapy , Oligopeptides/administration & dosage , Salvage Therapy/methods , Adrenal Cortex Hormones/adverse effects , Adrenal Cortex Hormones/therapeutic use , Adult , Aged , Aged, 80 and over , Anemia/chemically induced , Cyclophosphamide/adverse effects , Cyclophosphamide/therapeutic use , Disease-Free Survival , Female , Humans , Male , Middle Aged , Multiple Myeloma/complications , Multiple Myeloma/mortality , Neutropenia/chemically induced , Oligopeptides/adverse effects , Oligopeptides/therapeutic use , Recurrence , Salvage Therapy/adverse effects , Salvage Therapy/mortality , Survival Rate , Thrombocytopenia/chemically induced
2.
Genome Biol Evol ; 4(1): 59-72, 2012.
Article in English | MEDLINE | ID: mdl-22113794

ABSTRACT

The sister phyla dinoflagellates and apicomplexans inherited a drastically reduced mitochondrial genome (mitochondrial DNA, mtDNA) containing only three protein-coding (cob, cox1, and cox3) genes and two ribosomal RNA (rRNA) genes. In apicomplexans, single copies of these genes are encoded on the smallest known mtDNA chromosome (6 kb). In dinoflagellates, however, the genome has undergone further substantial modifications, including massive genome amplification and recombination resulting in multiple copies of each gene and gene fragments linked in numerous combinations. Furthermore, protein-encoding genes have lost standard stop codons, trans-splicing of messenger RNAs (mRNAs) is required to generate complete cox3 transcripts, and extensive RNA editing recodes most genes. From taxa investigated to date, it is unclear when many of these unusual dinoflagellate mtDNA characters evolved. To address this question, we investigated the mitochondrial genome and transcriptome character states of the deep branching dinoflagellate Hematodinium sp. Genomic data show that like later-branching dinoflagellates Hematodinium sp. also contains an inflated, heavily recombined genome of multicopy genes and gene fragments. Although stop codons are also lacking for cox1 and cob, cox3 still encodes a conventional stop codon. Extensive editing of mRNAs also occurs in Hematodinium sp. The mtDNA of basal dinoflagellate Hematodinium sp. indicates that much of the mtDNA modification in dinoflagellates occurred early in this lineage, including genome amplification and recombination, and decreased use of standard stop codons. Trans-splicing, on the other hand, occurred after Hematodinium sp. diverged. Only RNA editing presents a nonlinear pattern of evolution in dinoflagellates as this process occurs in Hematodinium sp. but is absent in some later-branching taxa indicating that this process was either lost in some lineages or developed more than once during the evolution of the highly unusual dinoflagellate mtDNA.


Subject(s)
Dinoflagellida/genetics , Evolution, Molecular , Genome, Mitochondrial , Recombination, Genetic/genetics , Transcriptome , Amino Acid Sequence , Base Sequence , Cell Culture Techniques , Codon, Terminator/genetics , DNA, Mitochondrial/genetics , Gene Amplification/genetics , Genes, rRNA/genetics , Mitochondria/genetics , Molecular Sequence Data , RNA Editing/genetics , RNA, Messenger/genetics , Transcription, Genetic/genetics
3.
J Appl Microbiol ; 111(3): 582-92, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21689222

ABSTRACT

AIMS: The aim of this study was to update and extend our knowledge of the bacterial load and microbial composition in Norway lobster (Nephrops norvegicus) under commercially relevant storage conditions to optimize handling procedures. METHODS AND RESULTS: Total viable counts were performed at different storage temperatures (0, 4, 8, 10, 12 or 16°C) and after different storage times (1-7 days). Storage at 16°C was found to be most detrimental, and storage at 0°C was found to be optimal. 16S-rRNA sequencing was utilized to determine the composition of the bacteria within the microflora. In this way, Photobacterium isolates, especially Photobacterium phosphoreum, were identified as the main specific spoilage organisms. The abilities to reduce trimethylamineoxide (TMAO) and to produce H(2)S were analysed in a selection of bacterial isolates. The higher the incubation temperature during storage, the more isolates were found to reduce TMAO and produce H(2)S. CONCLUSIONS: Nephrops norvegicus possesses an unusually high initial microbial load when fresh. Storage temperature is the most crucial factor affecting microbial growth, microbial activity and spoilage potential in N. norvegicus produce. Spoilage can be attributed mainly to P. phosphoreum. SIGNIFICANCE AND IMPACT OF THE STUDY: This study presents significant new findings with regard to the progression and causative agents of spoilage in N. norvegicus. Based on the results, we can recommend that N. norvegicus tails should be stored in a 0°C environment immediately after catch. Stored this way, the growth and spoilage activity of the microflora may be reduced significantly and an extension of shelf life might be attained.


Subject(s)
Bacterial Load , Food Storage/methods , Nephropidae/microbiology , Photobacterium/isolation & purification , Shellfish/microbiology , Animals , Cold Temperature , Colony Count, Microbial , DNA, Bacterial/genetics , Odorants/analysis , Photobacterium/genetics , Photobacterium/growth & development , Phylogeny , RNA, Ribosomal, 16S/genetics
4.
Mol Biol Rep ; 37(4): 2009-19, 2010 Apr.
Article in English | MEDLINE | ID: mdl-19642014

ABSTRACT

Calpains are ubiquitous cysteine-proteases found in many, if not all, living organisms and their roles within these organisms are diverse, ranging from the mediation of cytoskeletal remodeling to the regulation of gene expression. In crustaceans calpains have so far been shown to be important mainly during moulting and growth. In the present study we report the expression of a calpain in the abdominal muscle of Norway lobster (Nephrops norvegicus) using degenerate primer, rapid amplification of cDNA ends (5'-3'-RACE), reverse transcriptase-PCR and RNA in situ hybridization approaches. The full-length mRNA sequence (2,774 bp) was found to include an open reading frame (bp 225-1,940) encoding a 572 amino acid polypeptide with a predicted mass of 65.9 kDa and a predicted pI of 5.17. The calpain was found to be an arthropod M-class calpain homologue to Homarus americanus Calpain M (Ha-CalpM) and has thus been termed Nephrops norvegicus calpain M (Nn-CalpM). When its expression pattern in abdominal muscle of adult intermoult Nephrops norvegicus was investigated an exclusive expression in a thin layer of connective tissue cells surrounding muscle fibres was found. This localization suggests a role in tenderizing connective tissue networks during growth and moulting.


Subject(s)
Abdomen , Calpain/genetics , Muscles/enzymology , Nephropidae/enzymology , Amino Acid Sequence , Animals , Base Sequence , Calpain/chemistry , Cloning, Molecular , DNA, Complementary/genetics , Digoxigenin/metabolism , Gene Expression Regulation , In Situ Hybridization , Male , Molecular Sequence Data , Muscles/cytology , Norway , Phylogeny , Protein Transport , Reverse Transcriptase Polymerase Chain Reaction , Sequence Alignment , Sequence Analysis, DNA , Sequence Analysis, Protein
5.
J Clin Invest ; 96(3): 1238-44, 1995 Sep.
Article in English | MEDLINE | ID: mdl-7657797

ABSTRACT

Parathyroid hormone and other bone resorptive agents function, at least in part, by inducing osteoblasts to secrete cytokines that stimulate both differentiation and resorptive activity of osteoclasts. We previously identified two potentially important cytokines by demonstrating that parathyroid hormone induces expression by osteoblasts of IL-6 and leukemia inhibitory factor without affecting levels of 14 other cytokines. Although parathyroid hormone activates multiple signal transduction pathways, induction of IL-6 and leukemia inhibitory factor is dependent on activation of adenyl cyclase. This study demonstrates that adenyl cyclase is also required for stimulation of osteoclast activity in cultures containing osteoclasts from rat long bones and UMR106-01 rat osteoblast-like osteosarcoma cells. Since the stimulation by parathyroid hormone of both cytokine production and bone resorption depends on the same signal transduction pathway, we hypothesized that IL-6 might be a downstream effector of parathyroid hormone. We found that addition of exogenous IL-6 mimics the ability of parathyroid hormone to stimulate bone resorption. More importantly, an antibody directed against the IL-6 receptor blocks moderate stimulation of osteoclast activity induced by the hormone. Interestingly, strong stimulation of resorption overcomes this dependence on IL-6. Thus, parathyroid hormone likely induces multiple, redundant cytokines that can overcome the IL-6 requirement associated with moderate stimulation. Taken together with studies showing that many other bone resorptive agents also stimulate IL-6 production, our results suggest that IL-6 may be a downstream effector of these agents as well as of parathyroid hormone.


Subject(s)
Adenylyl Cyclases/metabolism , Bone Resorption , Interleukin-6/pharmacology , Osteoblasts/physiology , Osteoclasts/physiology , Parathyroid Hormone/pharmacology , Analysis of Variance , Animals , Animals, Newborn , Antibodies/pharmacology , Bone Neoplasms , Cell Line , Cells, Cultured , Enzyme Activation , Growth Inhibitors/pharmacology , Leukemia Inhibitory Factor , Lymphokines/pharmacology , Osteoblasts/cytology , Osteoblasts/drug effects , Osteoclasts/cytology , Osteoclasts/drug effects , Osteosarcoma , Peptide Fragments/pharmacology , Rats , Rats, Sprague-Dawley , Receptors, Interleukin/immunology , Receptors, Interleukin/physiology , Receptors, Interleukin-6 , Teriparatide , Tumor Cells, Cultured
6.
J Bone Miner Res ; 8(10): 1163-71, 1993 Oct.
Article in English | MEDLINE | ID: mdl-8256653

ABSTRACT

PTH and other hormones that stimulate resorption affect osteoclasts indirectly by modulating cytokine production by osteoblasts. However, the identity and role of the osteoblast-derived cytokines involved in this process are unclear. To examine which cytokines are regulated by PTH, we assessed cytokine mRNA levels in osteoblasts using the reverse transcription-polymerase chain reaction technique. Of the 16 cytokines we examined, unstimulated MC3T3-E1 osteoblastic cells expressed mRNA for interleukins 5, 6, and 7, macrophage and granulocyte-macrophage colony-stimulating factors, transforming growth factor beta 1, and leukemia inhibitory factor. PTH specifically increased expression of interleukin-6 (approximately 50-fold) and leukemia inhibitory factor (approximately 10-fold). Levels of both IL-6 and LIF mRNA peaked 30-60 minutes after addition of PTH and returned to baseline by 4-6 h. This rapid and transient mRNA response, which resembles that of immediate early genes, was also observed in primary rat osteoblasts. The transient mRNA response was accompanied by increased secretion of IL-6 protein. Lipopolysaccharide, another stimulator of resorption, increased mRNA levels of a group of cytokines that were not induced by PTH, namely interleukin-1 alpha, tumor necrosis factor alpha, and granulocyte-macrophage and granulocyte colony-stimulating factors. We conclude that osteoblasts produce complex networks of cytokines that (1) are regulated by bone-resorptive agents and (2) may be involved in controlling bone resorption.


Subject(s)
Growth Inhibitors/biosynthesis , Interleukin-6/biosynthesis , Lymphokines/biosynthesis , Osteoblasts/drug effects , Parathyroid Hormone/pharmacology , 3T3 Cells , Animals , Cell Line , Cells, Cultured , Cytokines/biosynthesis , Cytokines/genetics , Growth Inhibitors/genetics , Interleukin-6/genetics , Leukemia Inhibitory Factor , Lipopolysaccharides/pharmacology , Lymphokines/genetics , Male , Mice , Osteoblasts/cytology , Osteoblasts/metabolism , Polymerase Chain Reaction , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats
SELECTION OF CITATIONS
SEARCH DETAIL